4H-CRCXL Mitigates RasV12-Induced Phenotypes in Glioblastoma Model of Drosophila
{{output}}
Glioblastoma (GBM), a Grade IV malignant brain tumor, accounts for over half of all gliomas and remains resistant to current therapies, requiring the development of novel treatment strategies. Aberrant Ras signaling and PI3K/Akt hyperactivation and RAF/MEK/ERK... ...
